Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Estudo e repositório cardíaco do aplicativo CHAMP (CHAMP)

13 de novembro de 2026 atualizado por: Lori Erickson

Estudo cardíaco do aplicativo CHAMP: avaliação de funções de software para monitoramento assíncrono de crianças com doença cardíaca congênita complexa em ambiente doméstico e repositório de dados

This is a multi-site research study with an optional research repository that will consist of clinically derived data and photographic or video images of patients in the home setting with complex health conditions to evaluate the safety and efficacy of the CHAMP® software platform, with data and photographic or video images input and/or uploaded by the parent or other legally authorized representative (LAR) of patients with complex congenital heart disease as a target population.

Visão geral do estudo

Status

Inscrevendo-se por convite

Intervenção / Tratamento

Descrição detalhada

Study objectives

  1. To evaluate whether data collection and transmission through the CHAMP software platform improves communication between health care providers and parents/LAR that positively affects the care of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated
  2. To determine the accuracy of data obtained regarding observation by parent or caregiver of the condition of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated.
  3. To evaluate the use of the CHAMP App for clinical purposes, including user satisfaction with the data entry, parental self-management, and transmission capabilities.
  4. To evaluate the real-world performance analytics (RWPA) of the CHAMP software platform for transfer of parent-entered data for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated.

Endpoints

  1. To demonstrate that parents and caregivers for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated can accurately identify and transmit to healthcare providers specific health-related data including intake of food, fluids and mediations; output, including urination, defecation, and vomiting; weight; vital signs including oxygen saturation as measured by pulse oximetry; heart rate as measured either by a heart rate monitor or manually by the parent or caregiver; and temperature, measured by a reliable thermometer; and the value and reliability of videos provided by parents and caregivers regarding behavior of pediatric study participants for use in evaluating participant's health status.
  2. To demonstrate that data obtained through the use of devices such as pulse oximeters, as entered into the app by parents and caregivers, provide valuable information regarding the health status of children with Complex Diagnoses in a home setting.
  3. To demonstrate characteristics of CHAMP through real world health analytics (RWHA), user experience analytics (UX), and product performance analytics (PPA).

The study duration is open-ended for safety, effectiveness, and performance of the CHAMP app. Unless consent is withdrawn, data will be kept and used for data analysis and, if consented to the research repository for multi-site research purposes indefinitely. At age 18, previously pediatric patients may be approached for reconsent.

Tipo de estudo

Observacional

Inscrição (Estimado)

1000

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • District of Columbia
      • Washington D.C., District of Columbia, Estados Unidos, 20010
        • Children's National Hospital
    • Florida
      • Miami, Florida, Estados Unidos, 33155
        • Nicklaus Variety Children's Hospital
    • Louisiana
      • New Orleans, Louisiana, Estados Unidos, 70118
        • Children's Hospital New Orleans
    • Missouri
      • Kansas City, Missouri, Estados Unidos, 64108
        • Children's Mercy Hospital
    • Ohio
      • Cincinnati, Ohio, Estados Unidos, 45219
        • Cincinnati Children's Hospital Medical Center
      • Columbus, Ohio, Estados Unidos, 43205
        • Nationwide Children's Hospital
    • Texas
      • Forth Worth, Texas, Estados Unidos, 76104
        • Cook's Children's
      • Houston, Texas, Estados Unidos, 77030
        • Children's Memorial Hermann Hospital
    • Utah
      • Salt Lake City, Utah, Estados Unidos, 84108
        • Primary Children's Hospital/University of Utah

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

Não mais velho que 18 anos (Filho, Adulto)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

Pediatric patients with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated in the home setting through a multi-regional approach.

Parents who utilize their CHAMP App and the healthcare team that log-in are also part of the CHAMP App study.

Descrição

Inclusion Criteria:

  • Age 0-17 years with a parent/Legally authorized representative
  • Diagnosed with a complex health condition in which asynchronous monitoring in the home setting is appropriate.
  • Pediatric patient's cardiac care team has decided that the patient's treatment plan may benefit from remote home monitoring.
  • Institution that the subject is followed through clinically has been an approved as site for the CHAMP app study with Children's Mercy Kansas City.

Adult participants

  • Parents/Legally authorized representatives of pediatric subject.
  • Healthcare team users at an institution that is an approved site for the CHAMP app Study with Children's Mercy Kansas City.

Exclusion Criteria:

  • Inability to be discharged to care in the home setting.
  • Those not meeting the above inclusion criteria.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: COHORT
  • Perspectivas de Tempo: OTHER

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Human factors/usability engineering: Login failures
Prazo: Over a 3 month period

Rate of attempts of log-in failures

Over a 3 month period
Human factors/usability engineering: Imprecision
Prazo: Over a 3 month period

Rate of data values reported with imprecision

Over a 3 month period
Clinical Safety: Anticipated adverse events
Prazo: Over a 3 month period

Anticipated Adverse event rates

Over a 3 month period
Clinical Safety: Event resolution- anticipated
Prazo: Time in days, reported over the last 3 months

Time to resolve anticipated adverse events

Time in days, reported over the last 3 months
Clinical Safety: Unanticipated Adverse events
Prazo: Time in days, reported over the last 3 months

Unanticipated adverse event rates

Time in days, reported over the last 3 months
Clinical Safety: Event resolution- unanticipated
Prazo: Time in days, reported over the last 3 months

Time to resolve unanticipated adverse events

Time in days, reported over the last 3 months
Health Benefits: Adherence
Prazo: Measurement of adherence to daily data entry per each patient/parent over 3 month period on non-hospitalized days, during the study period

Rate of adherence to daily data entry

Measurement of adherence to daily data entry per each patient/parent over 3 month period on non-hospitalized days, during the study period
User Satisfaction: Complaints
Prazo: Over a 3 month period

Complaint rates via the healthcare team web portal

Over a 3 month period
User Satisfaction CHAMP Video
Prazo: through study completion, an average of 9 months

Feedback from healthcare team will be received via treatment endpoint survey questions. Likert scale questions 1-strongly disagree to 5 strongly agree (Using CHAMP videos for the interstage monitoring of this patient improved clinical decisions for the home monitoring team). Available to put in comments.

through study completion, an average of 9 months
User Satisfaction: Communication
Prazo: through study completion, an average of 9 months

Feedback from healthcare team will be received via treatment endpoint survey questions Likert scale questions 1-strongly disagree to 5 strongly agree ( Using CHAMP for the interstage monitoring of this patient improved communication with the parents at home.) Available to put in comments.

through study completion, an average of 9 months
User Engagement
Prazo: Over a 3 month perriod

Total number of registered users (Active, treatment endpoint reached) and data totals per parent entered measure. De-identified Demographics and age areas utilization -Utilization across the number of pediatric sites, healthcare teams

Over a 3 month perriod
CHAMP app performance: Downtime
Prazo: Over a 3 month period

Product Performance Analytics measured through Any system downtime

Over a 3 month period
CHAMP app performance: Cybersecurity
Prazo: Over a 3 month period

Product Performance Analytics measured through Any reported breaches

Over a 3 month period
CHAMP app performance
Prazo: Quarterly review of CHAMP App Performance will be measure over the preceding 3 months for frequency of changes required

Product Performance Analytics measured through --Bug/defect rate or Version failure rates

Quarterly review of CHAMP App Performance will be measure over the preceding 3 months for frequency of changes required

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Lori Erickson, PhD, Director, Remote Health Solutions Children's Mercy

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

25 de agosto de 2023

Conclusão Primária (Estimado)

31 de dezembro de 2027

Conclusão do estudo (Estimado)

31 de dezembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

24 de agosto de 2023

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de setembro de 2023

Primeira postagem (Real)

13 de setembro de 2023

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

13 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Sim

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever